Spot On Sciences, Inc., an Austin-based medical device company, has been awarded a $225,000 grant to support research for a preanalytical, endogenous standard (PS). Currently, comparisons between blood sample types including wet and dried plasma/serum and capillary and venous whole blood is difficult. This standard would allow normalization between blood sample types which would increase control for sample quality and volume and would allow more precise analysis.
“Solving this problem will help everyone involved in the field of dried blood spots,” claims Dr. Jeanette Hill, founder and CEO of Spot On Sciences. “We are excited to improve test results with this new standard all from finger stick blood samples,” said Hill.
Spot On Sciences has developed HemaSpot™ devices (www.spotonsciences.com) to simplify collection, preservation and shipping of dried blood samples and to reduce pre-analytical errors such as sample contamination, humidity exposure and errors from remote and/or self-sampling. HemaSpot products are being used around the world for testing a wide range of analytes including small molecules, proteins and nucleotides.
About Spot On Sciences
Spot On Sciences, Inc., located in Austin, Texas, is a medical device company that is actively developing innovative methods for collecting and preserving biological fluid samples. The company’s products, HemaSpot™ devices, allow for simplified blood sample collection and storage for dried blood spot (DBS) testing. The firm’s success has been recognized with many awards including the Cartier Women’s Initiative Award (2011), SXSW Interactive Accelerator (2013), RISE Global Pitch Competition (2013), 1776 Challenge Cup – Health category (2014), the SXSW Austin Venture Awards (2014), Astia/WeOwnIt Venture Competition (2014), named North America champion in the Kauffman Foundation’s Global Pitch Competition and international finalist for Get In The Ring (2014). For more information visit the company’s website at www.spotonsciences.com.
Spot On Sciences